GCK may be an important point of intervention as T2DM patients exhibit downregulation of GCK expression and a patient with a GCK mutation that resulted in 8.5 times higher affinity for glucose demonstrated significantly higher β-cell proliferation rates compared to control patients [30,38,39]. The gene discussed is GCK; the disease is type 2 diabetes mellitus.